Investor Relations

Latest Financial Results

Q1 2024

Quarter Ended Mar 31, 2024

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Company Overview

Cryoport, Inc., is a global provider of innovative products and services to the fast-growing Cell & Gene Therapy industry - enabling the future of medicine for a new era of life sciences. With 50 strategic locations covering the Americas, EMEA (Europe, the Middle East and Africa) and APAC (Asia Pacific), Cryoport's global platform provides mission-critical bio-logistics, bio-storage, bio-processing, and cryogenic systems to the life sciences markets worldwide.

Stock Snapshot

IR Contacts


Cryoport, Inc.
112 Westwood Place
Suite 350
Brentwood, TN 37027

Investor Relations

Scott Eckstein

Todd Fromer

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place
8th Floor
New York, NY 10004
T: 212-509-4000